Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

NCT03957577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-02-22

No results posted yet for this study

Summary

The purpose of this prospective, epidemiological, cohort study is to evaluate the lung microbiome in stable-state chronic obstructive pulmonary disease (COPD) in Japanese participants

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Prospective observational cohort study

Prospective observational cohort study

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-13
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03957577 on ClinicalTrials.gov